Eris Lifesciences COO Krishnakumar Vaidyanathan Resigns, Plans to Join Biological E
Eris Lifesciences announced that Executive Director and COO Krishnakumar Vaidyanathan will resign effective September 30, 2026, to pursue opportunities outside the company. The resignation was accepted by the Chairman, with the company expressing appreciation for his contributions. Sources indicate Krishnakumar is set to join Hyderabad-based Biological E to lead its biopharma and CDMO business, BE BioSol, potentially as CEO. Krishnakumar joined Eris Lifesciences in 2020, previously working in pharma investment banking.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (50/100). Lens Score 38/100.
Outlets measured: moneycontrol, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (50–50/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 11 Sept, 11:48 am. Other outlets followed.